Answers are grounded in this paper and cite their sources.
The overall mortality at discharge of VV ECMO in the treatment of neonatal respiratory failure was 12%. Although complications are frequent, the survival rate during hospitalization is still high. Further larger samples, and higher quality of randomized controlled trials (RCTs) are needed to clarify the efficacy and safety of this technique in the treatment of neonatal respiratory failure.
No takes yet. Share an insight, caveat, or question.
Xiong et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: